Sundeep Agrawal, Esther Park, Paul G. Kluetz. "FDA approvals in 2024: new options for patients across cancer types and therapeutic classes." Nature Reviews Clinical Oncology (2025). https://doi.org/10.1038/s41571-025-01018-w